SF3B1 and glioblastoma: Moreover, ROC-curve analyses reinforced the potential prognostic capacity of the SF3B1 overexpression levels to significantly discriminate between classical/mesenchymal -GBM and proneural -GBM in both external patient cohorts [Rembrandt (Fig. 4f) and CGGA (Fig. 4g)].